Evidence for an endogenous peptide ligand for the phencyclidine receptor

Peptides ◽  
1984 ◽  
Vol 5 (5) ◽  
pp. 967-973 ◽  
Author(s):  
Remi Quirion ◽  
Debora A. DiMaggio ◽  
Edward D. French ◽  
Patricia C. Contreras ◽  
Joseph Shiloach ◽  
...  
2014 ◽  
Vol 21 ◽  
pp. 140-146 ◽  
Author(s):  
Satoshi Endo ◽  
Shigeyuki Betsuyaku ◽  
Hiroo Fukuda

2006 ◽  
Vol 26 (2) ◽  
pp. 131-158 ◽  
Author(s):  
Ramasubbu Sankararamakrishnan

One of the largest family of cell surface proteins, G-protein coupled receptors (GPCRs) regulate virtually all known physiological processes in mammals. With seven transmembrane segments, they respond to diverse range of extracellular stimuli and represent a major class of drug targets. Peptidergic GPCRs use endogenous peptides as ligands. To understand the mechanism of GPCR activation and rational drug design, knowledge of three-dimensional structure of receptor–ligand complex is important. The endogenous peptide hormones are often short, flexible and completely disordered in aqueous solution. According to “Membrane Compartments Theory”, the flexible peptide binds to the membrane in the first step before it recognizes its receptor and the membrane-induced conformation is postulated to bind to the receptor in the second step. Structures of several peptide hormones have been determined in membrane-mimetic medium. In these studies, micelles, reverse micelles and bicelles have been used to mimic the cell membrane environment. Recently, conformations of two peptide hormones have also been studied in receptor-bound form. Membrane environment induces stable secondary structures in flexible peptide ligands and membrane-induced peptide structures have been correlated with their bioactivity. Results of site-directed mutagenesis, spectroscopy and other experimental studies along with the conformations determined in membrane medium have been used to interpret the role of individual residues in the peptide ligand. Structural differences of membrane-bound peptides that belong to the same family but differ in selectivity are likely to explain the mechanism of receptor selectivity and specificity of the ligands. Knowledge of peptide 3D structures in membrane environment has potential applications in rational drug design.


Author(s):  
Patricia C. Contreras ◽  
Debora A. Dimaggio ◽  
Thomas L. O’Donohue ◽  
Rémi Quirion

1998 ◽  
Vol 251 (2) ◽  
pp. 471-476 ◽  
Author(s):  
Kazuhiko Tatemoto ◽  
Masaki Hosoya ◽  
Yugo Habata ◽  
Ryo Fujii ◽  
Tadao Kakegawa ◽  
...  

1995 ◽  
Vol 181 (2) ◽  
pp. 805-810 ◽  
Author(s):  
B L Hsu ◽  
B D Evavold ◽  
P M Allen

T cells potentially encounter numerous endogenous peptides during selection in the thymus and in the periphery. We examined the impact of an endogenous peptide on in vivo T cell development, using a TCR transgenic mouse model based on a hemoglobin-specific T cell clone. In these mice, the transgenic beta chains paired with endogenous alpha chains. This led to a serendipitous primary reactivity to Ser69 peptide, an altered peptide ligand of the Hbd (64-76) epitope of the parent clone. Two Ser69-reactive T cell populations were identified. A smaller population of the Ser69-reactive T cells responded both to Ser69 and Hbd (64-76). A majority reacted only to Ser69, and not to Hbd(64-76); in fact, Hbd(64-76) was a specific TCR antagonist for these Ser69-only-reactive T cells. Thus, in this unique experimental system, Ser69 became an agonist, and Hbd (64-76) was an antagonist. Endogenous presentation of the antagonist ligand in the thymus selectively eliminated the high-avidity cells, while sparing low-avidity cells in the Ser69-reactive T cell repertoire. These results highlight how specificity guides developing T cells through a network of ligands and indicate that the endogenous peptide pool has a profound effect on T cell development and repertoire.


Sign in / Sign up

Export Citation Format

Share Document